Lecture 10: NFkb Flashcards

1
Q

Five NFkB members

A
RelA (p65)
RelB
c-Rel
p50/p105 (NFkB1)
p52/p100 (NFkB2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

N terminal Rel-homology domain (RHD)

A

mediates DNA binding and dimerization of NFkB

RelA, RelB, c-Rel contain unrelated c terminal transcriptional activation domains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

p105 and p100

A

ubiquitin-dependent proteolytic processing removes C-terminal domain and result in production of mature DNA-binding proteins (p50 and p52)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common form of NFkB dimers

A

p50/p65 (NFkB1/RelA)

Rel B can only form heterodimers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

kB binding site symmetry

A

5’-GGGRNNYYCC-3’

each dimer subunit reacts with one half site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inhibitors of kappa B (IkBs)

A

IkB a

IkB b

other less studied forms are IkB gamma and BCL3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ank domains

A

IkB with Ank domains can interact with RHD sequences on Nf-kB and block the ability of NfkB dimers to bind DNA and nuclear translocation

most studied member is IkBa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

3 types of IkB kinase (IKK)

A

IKK-a
IKK-b
IKK-y (NEMO)

a and b together are catalytically active and y subunit serves as a regulatory function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does IKK activates NFkB activation cascade

A

phosphorylate IkB on Ser32 and Ser36

IkB recognize by B-TRCP and SCF (E3 ubiquitin ligase)

proteasomal degradation of IkB

p50/RelA translocate into nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NFkB can be activated by?

A

interleukin receptor (ILR) via TAK1

toll-like receptor (TLR) via TAK1

RTK and PI3K via AKT or tank binding kinase (TBK1)

Lymphocyte receptor via PKC

TNF receptor pathway activation TAK1 via RIPK1

PHOSPHORYLATES IKKy and activates its activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Non-canonical pathway of NFkB

A

NIK is activated by receptor ligation

phosphorylate IKKa and IKKb

proteasomal degradation of p100

RelB binds with p52 which has DNA binding activity

regulates distinct class of genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5 effects of NFkB transcription factors

A
  1. negative control of apoptosis (BCL2, BCLXL, CIAP1,2, XIAP survivin)
  2. cell proliferation (cyclin D, MYC)
  3. cell adhesion and motility (ICAM, VCAM, fibronectin, metalloproteinases)
  4. inflammation (IL-6)
  5. angiogenesis (VEGF, COX2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Negative feedback for NFkB

A
  1. induction of IkB proteins IkBa and IKB gamma
  2. induction of A20 (encoded by TNFAIP3), a ubiquitin-editing enzyme, negatively regulates IKK activity (prevent activation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NFkB activation in leukemia and lymphogenesis

A

constitutively active in response to growth factors and cytokines or viral oncoproteins

NFkB activation can lead to production of CD40 ligand which positive feedback to increase signalling

activates cyclin D1 and D2 (promote G1 to S phase)

activates inhibitor of apoptosis (BCL-XL, cIAPS and A1/BFL1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 pathways which contribute to induction of cyclin D1

A
  1. activation of AP1 by growth factors (GF) through MAPK
  2. activation of RANKL which binds to RANK and activated IKKa

promote G1 to S phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Role of NFkB in gastric and colorectal cancer

A

NFkB activation leads to production of inducible nitric oxide synthase (iNOS) and COX2

enhance production of ROS lead to DNA damage

enhance production of growth factors and cytokines can lead to further proliferation of transformed cells

17
Q

Antioxidant therapy

A

NFkB inhibitors to destroy ROS and RNS (reactive nitrogen species)

18
Q

Proteasome inhibitors

A

target 26S proteasome

19
Q

IkkB inhibitors

A

inhibit IKKB but can also have decrease affinity for IKKa

competitors for ATP binding which are required for IKKb activation

allosterically decrease IKK activity